KELSEY DIRUTIGLIANO: Open Payments
NPI 1215474853 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,300 in 55 payments from 18 companies in 2025. Trend: 2023 $1,708 · 2024 $1,765 · 2025 $1,300
Food & beverage: $1,300
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $387 |
| Novartis Pharmaceuticals Corporation | 13 | $165 |
| Novo Nordisk Inc | 3 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $78 |
| PFIZER INC. | 4 | $77 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Boston Scientific Corporation | 2 | $52 |
| Inspire Medical Systems, Inc. | 1 | $41 |
| Alnylam Pharmaceuticals Inc. | 1 | $35 |
Products named: Adempas, LEQVIO, Wegovy, JARDIANCE, EVKEEZA, VYNDAQEL, CDS - MCT/CEM Monitoring, Kerendia.
Industry payments across OH — which companies pay providers there.
